Skip to content

Investigation of response of glioblastomas to cytotoxic drugs in vitro (ivt Study)

Investigation of response of glioblastomas to cytotoxic drugs in vitro (ivt Study) - ivt

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00000264
Enrollment
88
Registered
2009-11-13
Start date
2008-09-01
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

glioblastoma C71.9

Interventions

None listed

Sponsors

Universitätsklinikum Rheinisch-Westfälische Technische Hochschule Aachen
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: new radiological diagnosis of a malignant glioma (MRT based) indication for surgical resection Karnofsky index of at least 70% no principal denial of chemotherapy no serious hematological, liver, kidney abnormalities precluding chemotherapy written informed consent of the patient

Exclusion criteria

Exclusion criteria: younger than 18 or older than 75 years preoperative a/o intraoperative verification of a pathology, incompatible with a malignant glioma (WHO grade III/IV) no histologically confirmed glioblastoma tumor infiltrates areas of the brain that preclude an adequate radiation dose prior tumor surgery or other treatment Karnofsky index of less than 70% severe cardiovascular disease severe hematological impairment, kidney a/o liver insufficiency which preclude chemotherapy stroke serious infection basic unwillingness to receive chemotherapy other malignancies (except basalioma) pregnancy or lactation women in childbearing age if contraception cannot be warranted dementia or other mental state which precludes comprehension of therapy and hence, informed consent

Design outcomes

Primary

MeasureTime frame
time to progression (TTP)

Secondary

MeasureTime frame
overall survival (OS)

Countries

Belgium, Germany, Netherlands

Contacts

Public ContactFrank Oertel

Universitätsklinikum Rheinisch-Westfälische Technische Hochschule Aachen

mfoertel@ukaachen.de+49-0241-8088501

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026